CAR-T boxed warnings: What comes next?

Update: 2024-03-06

Description

The FDA recently asked the six marketed CAR-T therapies to add a new boxed warning item on their labels to reflect the risk of secondary T-cell cancers. This decision follows an investigation into the new safety signal from postmarketing adverse event reports and clinical trials.

In today’s episode, Fierce Pharma’s Angus Liu talks with Parexel regulatory experts Mwango Kashoki, M.D., Senior Vice President, Global Head of Regulatory Strategy, and Steve Winitsky, M.D., Vice President, Technical - Regulatory Strategy, to understand the rationale behind the FDA’s decision and to discuss its implications for CAR-T candidates and their developers down the line.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Navigating market access in neuroscience: Challenges and strategies

2024-10-1626:22

Leveraging people, processes and technology to deliver for biotech

2024-10-0122:02

De-risking Drug Development | Episode 5: Expand the use and value of your product over time

2024-09-2534:38

De-risking Drug Development | Episode 4: Implement market launch strategy, pre-approval

2024-09-2533:53

Podcast: Accelerated approvals – what’s next, confirmatory trials, access, and pricing

2024-08-0512:51

De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept

2024-07-1639:29

Enabling Successful Sites Ep. 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

2024-06-2827:09

Enabling Successful Sites Ep. 3: Taking the complexity out of oncology trials

2024-06-2826:40

De-risking Drug Development | Episode 2: Focus on safety and efficacy and prove quickly that your product works

2024-06-1938:13

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

2024-05-2323:37

Enabling Successful Sites, Episode 1: Solving Site Feasibility and Start-Up Challenges

2024-05-1016:40

Rare Endpoints: Delivering on Unmet Patient Needs

2024-05-0711:19

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 3

2024-04-2513:22

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 2

2024-04-2513:27

Advancing Precision Oncology: Expanding Patient Access to Biomarkers and Testing Capabilities Part 1